» Articles » PMID: 23975843

When Do We Need Competing Risks Methods for Survival Analysis in Nephrology?

Overview
Date 2013 Aug 27
PMID 23975843
Citations 280
Authors
Affiliations
Soon will be listed here.
Abstract

Survival analyses are commonly applied to study death or other events of interest. In such analyses, so-called competing risks may form an important problem. A competing risk is an event that either hinders the observation of the event of interest or modifies the chance that this event occurs. For example, when studying death on dialysis, receiving a kidney transplant is an event that competes with the event of interest. Conventional methods for survival analysis ignoring the competing event(s), such as the Kaplan-Meier method and standard Cox proportional hazards regression, may be inappropriate in the presence of competing risks, and alternative methods specifically designed for analysing competing risks data should then be applied. This problem deserves more attention in nephrology research and in the current article, we therefore explain the problem of competing risks in survival analysis and how using different techniques may affect study results.

Citing Articles

Kidney Transplant Fast Track and Likelihood of Waitlisting and Transplant: A Nonrandomized Clinical Trial.

Myaskovsky L, Leyva Y, Puttarajappa C, Kalaria A, Ng Y, Velez-Bermudez M JAMA Intern Med. 2025; .

PMID: 40063052 PMC: 11894542. DOI: 10.1001/jamainternmed.2025.0043.


Ultra-processed food, genetic predisposition, and the risk of kidney stone: a population-based prospective cohort study.

Bai S, Zhang Y, Liu Y, Yang H, Jiang J, Chang Q Eur J Nutr. 2025; 64(2):103.

PMID: 40025295 DOI: 10.1007/s00394-025-03623-y.


Comparison of seven models for the progression patterns of multiple chronic conditions in longitudinal studies.

Baneshi M, Mishra G, Dobson A BMJ Public Health. 2025; 2(2):e000963.

PMID: 40018552 PMC: 11816716. DOI: 10.1136/bmjph-2024-000963.


Incidence and contributing factors of dementia among people living with HIV in British Columbia, Canada, from 2002 to 2016: a retrospective cohort study.

Shayegi-Nik S, Honer W, Vila-Rodriguez F, Nanditha N, Patterson T, Guillemi S BMJ Public Health. 2025; 2(1):e000627.

PMID: 40018107 PMC: 11816979. DOI: 10.1136/bmjph-2023-000627.


Incidence of Newly Diagnosed Cancer After Cerebral Venous Thrombosis.

van de Munckhof A, Verhoeven J, Vaartjes I, van Es N, de Leeuw F, Coutinho J JAMA Netw Open. 2025; 8(2):e2458801.

PMID: 39928336 PMC: 11811797. DOI: 10.1001/jamanetworkopen.2024.58801.